By Ahmed Aboulenein WASHINGTON, Feb 1 (Reuters) - The U.S. Food and Drug Administration on Sunday began accepting requests to ...
XINTAI, SHANDONG, CHINA, January 19, 2026 /EINPresswire.com/ -- In recent years, the global pharmaceutical packaging ...
According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...
FDA Commissioner Marty Makary, M.D., M.P.H., characterized the program as a “bold step” to bring manufacturing back to the US and make the domestic sector more resilient and competitive. This program ...
As supply chain vulnerabilities intensify and competition accelerates, the cost of this underutilization could risk India's ...
The FDA laid out the qualifications a site would need to qualify for PreCheck on a webpage where companies can also submit ...
The FDA launched PreCheck pilot program to strengthen U.S. drug supply chain by improving regulatory predictability.
Historically a steel production hub, Lehigh Valley will now help manufacture Lilly’s weight loss drug hopeful retatrutide.
For much of the past decade, drug shortages in the United States were treated as episodic disruptions. In 2024, that framing ...
Operating under the FDA's 503B pathway, the Apex facility will prioritize the production of generic shortage-listed ...
The U.S. House of Representatives Committee on Energy and Commerce's Subcommittee on Health held a recent hearing titled "Made in America: Strengthening Domestic Manufacturing and the Health Care ...
Tens of thousands of cholesterol medication bottles are being recalled nationwide due to manufacturing issues that could reduce drug potency and effectiveness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results